2003-2009 Akdeniz Üniversitesi Tıp Fakültesi
2009-2014 Fırat Üniversitesi Tıp Fakültesi Kardiyoloji Anabilim Dalı

2009 Kemaliye Devlet Hastanesi, Pratisyen Hekim
2009- 2014 Fırat Üniversitesi Hastanesi, Kardiyoloji Departmanı
2014-2016 Viranşehir Devlet Hastanesi, Kardiyoloji Departmanı
2016-2022 Başkent Üniversitesi Hastanesi, Kardiyoloji Departmanı

Koroner Yoğun Bakım (Sertifikalı)
Koroner Arter Hastalıkları
Girişimsel Kardiyoloji Uygulamaları
Kalp Kapak Hastalıkları
Kalp Yetmezliği 
Kalp Transplantasyonu

Türk Kardiyoloji Derneği
Avrupa Kardiyoloji Derneği
Kardiyovasküler Akademi Derneği  
Türk Organ Nakli Derneği

Kongre Türk Kardiyoloji Derneği Kongresi 2019-2020 
Ulusal Aritmi Kongresi 2016-2020 
Ulusal Girişimsel Kardiyoloji Toplantısı 2020 
Türk Dünyası Organ Nakli Derneği Toplantısı 2018

  1. Prevalence and Angiographic Characteristics of CoronaryVasospasm Detected at Surveillance Coronary AngiogramsAmong Patients With Heart Transplants. ARZU NESLİHAN AKGÜN,ORÇUN ÇİFTÇİ,KEREM CAN YILMAZ,EMİR KARAÇAĞLAR,ALP AYDINALP,ATİLLA SEZGİN,İBRAHİM HALDUN MÜDERRİSOĞLU,MEHMET HABERAL (01.11.2017 -03.11.2017 ) , Yayın Yeri:2nd Joint Meeting of Turkish Transplantation Society (TOND) and Turkic World Transplantation Society (TDTD) , 2017
  2. Posttransplant Pulmonary Hypertension Is Correlated With Acute Rejection and Death Among Cardiac Transplant Recipients: A Single Center Study. ORÇUN ÇİFTÇİ,ARZU NESLİHAN AKGÜN,KEREM CAN YILMAZ,EMİR KARAÇAĞLAR,ALP AYDINALP,ATİLLA SEZGİN,İBRAHİM HALDUN MÜDERRİSOĞLU,MEHMET HABERAL (01.11.2017 -03.11.2017 ) , Yayın Yeri:2nd Joint Meeting of Turkish Transplantation Society (TOND) and Turkic World Transplantation Society (TDTD) , 2017.
  3. Kalıcı Pacemaker İmplantasyonu Sonrası Prilokaine Bağlı Gelişen Bir Methemoglobinemi Vakası. ARZU NESLİHAN AKGÜN,ORÇUN ÇİFTÇİ,KEREM CAN YILMAZ,MEHMET BÜLENT ÖZİN,İBRAHİM HALDUN MÜDERRİSOĞLU (04.05.2017 -07.05.2017 ) , Yayın Yeri:2017 Ulusal Aritmi Toplantısı , 2017.
  4. The use of new oral anticoagulants in octogenarian patients with non-valvular atrial fibrillation (single center experience). EMİR KARAÇAĞLAR,ARZU NESLİHAN AKGÜN,KEREM CAN YILMAZ (03.10.2019 -06.10.2019 ) , Yayın Yeri:35th International Participation inTurkish Cardiology Congress , 2019
  5. The effect of renal transplantation on cardiac functions. KEREM CAN YILMAZ,ARZU NESLİHAN AKGÜN (03.10.2019 -06.10.2019 ) , Yayın Yeri:35th International Participation inTurkish Cardiology Congress , 2019
  6. Gensini skoru pompa destekli koroner arter baypas greftleme sonrasi gelişen atriyal fibrilasyonun öngördürücüsüdür. EMİR KARAÇAĞLAR, ARZU NESLİHAN AKGÜN,ORÇUN ÇİFTCİ,İBRAHİM HALDUN MÜDERRİSOĞLU , Yayın Yeri:Turkish Journal of Clinics and Laboratory , 2020
  7. Successful Treatment of a Rare Complication in a Heart Transplant Recipient: Spontaneous Axillary Artery Bleeding. EMİR KARAÇAĞLAR, ARZUNESLİHAN AKGÜN,CÜNEYT AYTEKİN,ALP AYDINALP,ATİLA SEZGİN,İBRAHİM HALDUN MÜDERRİSOĞLU , Yayın Yeri:Experimental and Clinical Transplantation , 2019
  8. Adequacy of Infective Endocarditis Prophylaxis Before Dental Procedures Among Solid Organ Transplant Recipients. EMİR KARAÇAĞLAR, ARZU NESLİHAN AKGÜN, ORÇUN ÇİFTCİ,NUR ALTIPARMAK,İBRAHİM HALDUN MÜDERRİSOĞLU,MEHMET HABERAL , Yayın Yeri:Saudi Journal of Kidney Diseases and Transplantation , 2019
  9. The Role of Selvester Score on 12-Lead ECG in Determination of Left Ventricular Systolic Dysfunction Among Patients Receiving Trastuzumab Therapy. ORÇUN ÇİFTCİ, KEREM CAN YILMAZ,EMİR KARAÇAĞLAR,Arzu Neslihan Akgün,MUSTAFA YILMAZ,ARZU OĞUZ,İBRAHİM HALDUN MÜDERRİSOĞLU , Yayın Yeri:European Journal of Therapeutics , 2019
  10. Kalp Nakil Alıcılarında Tp-e Mesafesi, Tp-e/QT Oranı veTp-e/QTc Oranının Asemptomatik Rejeksiyonla İlişkisi. EMİR KARAÇAĞLAR, ARZU NESLİHAN AKGÜN , Yayın Yeri:MN Kardiyoloji , 2019
  11. Relation of Preoperative and Postoperative Echocardiographic Parameters With Rejection and Mortality in Liver Transplant Patients. KEREM CAN YILMAZ, ORÇUN ÇİFTCİ, Arzu Neslihan Akgün,İBRAHİM HALDUN MÜDERRİSOĞLU,AHMET SEDAT BOYACIOĞLU,ASUMAN NİHAN HABERAL REYHAN,GÖKHAN MORAY,MEHMET HABERAL , Yayın Yeri:Experimental and Clinical Transplantation , 2020
  12. Risk Factors For Left Atrial Appendage Thrombus. KEREM CAN YILMAZ, ARZU NESLİHAN AKGÜN, ORÇUN ÇİFTCİ, SERPİL EROĞLU,BAHAR PİRAT,LEYLA ELİF SADE AKDOĞAN ,MELEK ZEKİYE ULUÇAM,MEHMET BÜLENT ÖZİN,İBRAHİM HALDUN MÜDERRİSOĞLU , Yayın Yeri:Acta Cardiologica , 2020
  13. Preoperative Cardiac Risk Assessment in Renal Transplant Recipients: A Single-Center Experience. Yilmaz KC, Akgün AN, Ciftci O, Muderrisoglu H, Sezer S, Moray G, Haberal M. Exp Clin Transplant. 2019 Aug;17(4):478-482. doi: 10.6002/ect.2017.0145. Epub 2017 Oct 12. PMID: 29025386.
  14. Coronary Angiography for Follow-up of Heart Transplant Recipients: Usefulness of the Gensini Score. Karaçağlar E, Akgün AN, Müderrisoğlu IH, Haberal M.. Exp Clin Transplant. 2020 Jan;18(Suppl 1):99-104. doi: 10.6002/ect.TOND-TDTD2019.P37. PMID: 32008508.
  15. Incidence of Cardiovascular Events After Renal Transplantation. Karaçağlar E, Akgün AN, Müderrisoğlu IH, Haberal M. Exp Clin Transplant. 2020 Jan;18(Suppl 1):70-72. doi: 10.6002/ect.TOND-TDTD2019.P18. PMID: 32008500.
  16. Comparison of non-vitamin K antagonist oral anticoagulants and well-controlled warfarin in octogenarians with non-valvular atrial fibrillation: Real-world data from a single tertiary center. Akgün AN, Karaçağlar E, Bal UA, Özin B. 2021 (Anatolian Journal of Cardiology kabul edildi).

 

ARAŞTIRMACI OLDUĞUM ULUSLARARASI ÇALIŞMALAR

 

  • The Non-ST Myocardial Infarction Registry. EURObservational Research Programme

The aim of the EURObservational Research Programme (EORP) NSTEMI registry is to improve the clinical outcomes of patients hospitalised with NSTEMI, through the identification and reporting of sub-optimal delivery of guideline-indicated care.

First Posted  : 2019

Recruitment Status  : Active, not recruiting

  • A Multi-center, Randomized, Double-blind, Active-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Ramipril on Morbidity and Mortality in High Risk Patients Following an Acute Myocardial Infarction (Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI) (PARADISE-MI).

ClinicalTrials.gov Identifier: NCT02924727

First Posted  : October 5, 2016

Last Update Posted  : October 6, 2020

The purpose of this study is to evaluate the efficacy and safety of LCZ696 titrated to a target dose of 200 mg twice daily, compared to ramipril titrated to a target dose of 5 mg twice daily, in addition to conventional post-AMI treatment, in reducing the occurrence of composite endpoint of CV death, HF hospitalization and outpatient HF (time-to-first event analysis) in post-AMI patients with evidence of LV systolic dysfunction and/or pulmonary congestion, with no known prior history of chronic HF..

  • A 24-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Effect of LCZ696 on NT-proBNP, Exercise Capacity, Symptoms and Safety Compared to Individualized Medical Management of Comorbidities in Patients With Heart Failure and Preserved Ejection Fraction (A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients) (PARALLAX)

ClinicalTrials.gov Identifier: NCT03066804

Recruitment Status  : Completed

First Posted  : February 28, 2017

Last Update Posted  : August 5, 2020

The purpose of this study is to demonstrate the superiority of LCZ696 over individualized medical therapy for comorbidities in reducing N-terminal pro-brain natriuretic peptide (NT-proBNP) and improving exercise capacity and HF symptoms in patients with heart failure with preserved ejection fraction (HFpEF).

  • The Framework Programme for Research and Innovation. Health – Status  Monitor. Pre-commercial Procurement of innovative ICT-enabled monitoring to improve health status and optimise hypertension care. Horizon 2020 (Faz 1 ile yeni başlayan çalışma)

1 Adet Yorum

64x64
Hatice Ü. 
  16.04.2022

Arzu hocam güler yüzlü ve yaşına rağmen çok bilgili. Sorularımıza içten ve profesyonel şekilde yaklaşıp tedavimi başarıyla yaptı. Teşekkür ediyorum kendisine

Değerli Yorumlarınızı Bekliyoruz.